Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-23-021563

CHAIRMAN AND CEO bought 400,000 shares at $0.03 ($13,040)

From the SEC's structured data for this filing

Trades in this filing

Trieu Vuong · CHAIRMAN AND CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-14 Purchase : show line 1 in the form +400,000 $0.03 $13,040 91,444,217 D
Open-market purchases · 400,000 sh · avg $0.03 · $13,040
Loading xslF345X04/ownership.xml…